glp 1 agonist anesthesia Glucagon-Like Peptide Receptor Agonists and Aspiration Risk GLP-1 Agonists: A Comprehensive Overview

Brussels: International Diabetes Federation International Diabetes Federation

What studies show: Clinical trials in people with type 2 diabetes showed that tirzepatide led to significant reductions in body weight, with average weight loss ranging from about 5%--14% across various studies

[28] Normally, this would be a concern, since insulin can be considered the "energy storage hormone", but its appetite suppressive properties (due to delayed gastric emptying) tilt the scales towards more weight loss -- the point where it's become more than just antidiabetic drug

Adv Therapy

GLP-1 receptor agonists act on the pancreas by enhancing insulin secretion, inhibiting glucagon release (see #4 below), and there is some evidence to suggest that they protect the beta cells from damage

Maybe you should opt for Wegovy or Mounjaro for weight loss